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ABSTRACT
OPIOID USE IN THE CESAREAN SECTION PATIENT WITH THE
PREOPERATIVE ADMINISTRATION OF INTRAVENOUS ACETAMINOPHEN
by Dana Edwards Bernardo
December 2016
Cesarean sections are one of the most common surgical procedures and there are
no current guidelines for the management of postoperative pain control (Darvish,
Ardestani, Shali, & Tajik, 2013). Unresolved pain in this population can lead to long
lasting problems, such as chronic pain and depression (Booth, Harris, Eisenach, & Pan,
2015). The goal of multimodal therapy with IV acetaminophen for CS mothers was to
ensure a rapid and safe recovery process with reduced adverse complications and
shortened hospital length of stay. The independent t-test was used to compare the mean
time for length of stay, first request of pain medication, and total morphine equivalents
needed 24-hours and 48-hours post-cesarean section between the treatment group, Group
A and control group, Group C.
The results reflected that the preoperative administration of IV acetaminophen
reveal that Group A had a shorter length of stay than Group C. The difference was
statistically significantly different (p = 0.022). The amount of time for first request of
pain medication was compared. Group A had a shorter length of time for first request of
pain medication compared to Group C. The difference was not statistically significantly
different (p =0.299) indicating Group C had a longer time for opioid/analgesic
intervention compared to Group A. Morphine milligram equivalents (MME) were
compared between the two groups between 24 and 48 hours. The mean MME for Group
ii

A and Group C was not statistically significantly different (p = 0.299) indicating there
was no difference in MME between the two groups. The MME of 48 hours was higher in
Group A than Group C and this difference was statistically significantly different (p =
0.002) indicating that those who did not receive preoperative administration of IV
acetaminophen had a lower MME consumption.
Keywords: Ofirmev, paracetamol, intravenous acetaminophen, cesarean sections,
postoperative pain control, multimodal analgesia
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CHAPTER I – INTRODUCTION
Surgical pain experienced by any patient can be challenging for caregivers to
regulate effectively. Managing postoperative pain for the cesarean section (CS) patient is
different from other surgical procedures (Cancado, Omais, Ashmawi, & Torres, 2012).
Treatment of acute pain for the CS mother should be fast and safe in order to effectively
take care of the newborn (Cancado et al., 2012). If acute pain is not managed properly
for CS mothers, unresolved pain can lead to chronic pain for 10-15% of mothers
(Orbach-Zinger et al., 2014). The development of postpartum depression and posttraumatic stress disorder can also occur while enduring acute pain during childbirth
(Orbach-Zinger et al., 2014). In addition to decreased comfort, acute pain can cause
many adverse complications by stimulating the sympathetic nervous system (SNS),
leading to tachycardia, hypertension, and arrhythmias (Nagelhout & Plaus, 2014).
Unrelieved pain has been linked to metabolic disturbances by interfering with the
endocrine system, impairing cognitive function, depressing the immune system, and
inducing high anxiety states, which in turn affects digestion, heart rate, breathing and
other key bodily functions (Nagelhout & Plaus, 2014).
Background
Cesarean sections are increasing every year and there is concern for maternal
health relating to this type of delivery (Cancado et al., 2012). The common complaint for
these patients is postoperative pain (Orbach-Zinger et al., 2014). These patients present
with distinct challenges with the use of opioids. In addition to the aforementioned
problems to which pain can contribute to, other impairments found in the cesarean patient
related to the use of opioids are decreased alertness and stamina needed
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to take care of and breastfeed their newborn child (Ismail, Shahzad, & Shafiq,
2012). Instead of utilizing opioids only, a multimodal approach should be implemented
when treating postoperative pain for cesarean deliveries (Valentine, Carvalho, Lazo, &
Riley, 2015).
The American Society of Anesthesiologists Task Force on Acute Pain urges
multimodal pain control methods unless contraindicated (Nishimoto, 2014). Multimodal
analgesia involves the combination of opioids along with nonopioid analgesics or NOPAs
(Pogatzki-Zahn, Chandrasena, & Schug, 2014). Most commonly, NOPAs are
recommended as the choice agent and opioids are to be used as supplemental agents. The
NOPAs’ efficacy and safety should not be a concern and should provide favorable results
for pain control (Pogatzki-Zahn et al., 2014). Incorporating a multimodal approach to
reducing acute pain and promoting comfort may help avert the long-term effects of
chronic pain and depression that occur in CS patients (Booth, Harris, Eisenach, & Pan,
2015).
Significance
Postoperative pain negatively affects the patient’s quality of life. Adverse effects
of improper pain management by the anesthesia provider before and during surgery can
lead to physical and emotional complications postoperatively (Pasero & Stannard, 2012).
Ambulation can be delayed which can lead to venous thromboembolism, rehabilitation
can be shortened or missed, depression and anxiety may develop, and hospital
readmissions can occur (Pasero & Stannard, 2012). These compounded problems can
lead to decreased patient satisfaction (Cancado et al., 2012). Therefore, pain
management should be a primary concern for the anesthesia provider. The goal of the
2

anesthesia provider is to provide the safest and the best pain control methods to enable
the safest and easiest recovery possible.
Clinical Question
Does the use of preoperative administration of IV acetaminophen decrease the use
of opioids compared to those who do not receive IV acetaminophen by women who have
given birth by CS? Cesarean section is one of the most common procedures in the field
of obstetric/gynecologic (OB/GYN), yet there are no guidelines for treating post-cesarean
pain (Darvish et al., 2013).
Hamilton and colleagues (2015) reveal that of the 51.4 million surgical
procedures that take place annually in the United States alone, approximately 1.3 million
of these surgical procedures are CS. Frequency of cesarean sections surgeries is second
only to arteriography and angiocardiography (Hamilton et al., 2015). Because long
lasting effects can arise from insufficient analgesia, an alternative approach for post CS
pain is indicated. An estimated 30%-40% of CS patients experience moderate to severe
pain postoperatively, which can lead to fear, anxiety, and depression (Ayatollahi, Faghihi,
Behdad, Heiranizadeh, & Baghianimoghadam, 2014). When CS pain is managed
appropriately ensuring a safe and rapid recovery, a CS mother could have more favorable
results from breastfeeding and bonding experiences with her child (Niklasson, Arnelo,
Ohman, Segerdahl, & Blanck, 2015).
Problem Statement
In the United States, cesarean section (CS) accounts for more than 25% of all
deliveries (Kessous, et al. 2012). There is a marked increase in CS that can be attributed
to legal issues within the obstetrics/gynecological (OB/GYN) departments, as well as an
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increase in the number of mothers, that due to their age or their socioeconomic class, are
considered high-risk (Darvish et al., 2013). With the dramatic increase in cesarean
deliveries performed each year, the management of postoperative pain and other
complications is becoming more relevant than ever before (Darvish et al., 2013).
Insufficient analgesia can create long-term problems; in contrast, the safe,
uncomplicated, and rapid recovery CS mothers receive via multimodal treatment can help
reduce adverse complications, shorten the hospital stay, and improve breastfeeding,
which leads to quality bonding between a mother and her child (Niklasson et al., 2015).
Also, effective management of the acute surgical pain experience in CS patients can help
prevent future problems with chronic pain and depression (Booth et al., 2015).
Purpose of the Project
The purpose of this doctoral project is to foster a change in clinical practice for
the management of postoperative pain for CS patients. The use of a multimodal approach
with nonopioids, such as IV acetaminophen and opioids as a supplement for break
through pain, is becoming increasingly commonplace in many surgical procedures
(Lachiewicz, 2013). This study explored the impact of preoperative administration of IV
acetaminophen and determined if the administration reduced the mean time for length of
stay, first request of pain medication, and the total morphine equivalents needed 24-hours
and 48-hours post-cesarean delivery when compared to those who did not receive IV
acetaminophen prior to CS.
Length of stay was calculated in hours beginning with anesthesia start time and
ended when the patient was discharged from the hospital. The time of first request of
pain medication was calculated in minutes and hours starting with the anesthesia time
4

until the patient first asked for pain medication. Total morphine milligram equivalents
were calculated by totaling the analgesics given in a 24-hour and 48-hour time period.
Acetaminophen History and Trade Names
For over a century acetaminophen has been used as a safe and effective
medication for analgesia, as well as an antipyretic in both oral and rectal suppository
forms (Pasero & Stannard, 2012). It was first synthesized in 1878, with clinical use
starting worldwide the following year; however, it was not until the 1950s that
acetaminophen was sold in the United States (Pasero & Stannard, 2012). Since then, it
has become one of the most conventional and best known medications for the treatment
of fever and mild to moderate pain for children and adults (Pasero & Stannard, 2012).
Ofirmev®, also known as paracetmol in Europe, is the intravenous version of
acetaminophen. In 2001, paracetamol was manufactured by Cadence Pharmaceuticals
and was available for use in over 80 countries, excluding the United States (Buck, 2011).
The Food and Drug Administration (FDA) granted permission on November 2, 2010, for
the use IV of Ofirmev®, in the United States (Buck, 2011). The FDA supports the use of
IV acetaminophen for: “1) the management of mild to moderate pain; 2) the management
of moderate to severe pain with adjunctive opioid analgesics; and 3) the reduction of
fever in adults and children (age ≥ 2 years)” (Pasero & Stannard, 2012, p. 108).
Because IV acetaminophen avoids the first-pass metabolism, the drug spares the
liver from 50% of exposure compared to the oral or rectal form of acetaminophen (Lewis,
2012). The elimination of the first-pass metabolism and the rapid onset of IV
acetaminophen is quicker and more predictable than other available routes (Pasero &
Stannard, 2012).
5

Cost of Acetaminophen
Despite the reported benefits and the elimination of the hepatic first pass
metabolism, the cost of the product decreases its availability (McKee, 2014). When the
price of IV acetaminophen increased 140%, from approximately $14.00 per 1 gm vial to
$35.00 per 1 gm vial (Dungy & Prince, 2015) many hospitals responded to the substantial
rise in costs by decreasing their use of the product, thereby decreasing the availability of
the drug.
Acetaminophen Mechanism
IV acetaminophen is an analgesic and an antipyretic with a site of action that is
speculated to occur at the central nervous system (Lachiewicz, 2013). Its analgesic
properties are theorized to act by inhibiting prostaglandins, which then act peripherally
by blocking pain impulses, specifically a cannabinoid receptor agonist mechanism, a
serotonergic (5-HT) mechanism, cyclooxygenase-3 isoenzyme inhibition, and TRPVagonist (Lachiewicz, 2013). The antipyretic effect also is caused also by prostaglandin
inhibition within the hypothalamus and the subsequent blocking of the cannabinoid
agonist mechanism (Pasero & Stannard, 2012).
Route Comparisons Supporting IV Administration
In comparisons of by mouth (PO), per rectum (PR), and IV forms of
acetaminophen, the IV form has significantly higher peak concentrations in cerebrospinal
fluid (CSF) because high plasma concentrations are readily able to cross the blood brain
barrier (Lachiewicz, 2013). This is important, since acetaminophen is believed to work
centrally. Passive diffusion of acetaminophen into the central nervous system via the
blood brain barrier is dependent on Cmax (maximum plasma concentration of drug) since
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active transport does not occur (Singla et al., 2012). Also, there is less variability in the
plasma concentrations in cases where IV acetaminophen is delivered instead of the PO or
PR form (Singla et al., 2012).
The advantages of the IV form of acetaminophen over the PO route lie primarily
in its concentration and its onset time. For acetaminophen to be an effective analgesic,
serum therapeutic level should be 16 mcg/mL in adults (Golembieewski & Mueller,
2011). It takes 45 minutes for the onset of action to occur for 1,000 mg of PO
acetaminophen and most patients are unable to reach median plasma concentrations of
12mcg/mL (Golembieewski & Mueller, 2011). The PR form of acetaminophen is
unpredictable, and the maximum plasma concentration (Tmax) time can take up to three
to four hours (Lachiewicz, 2013). In contrast, IV acetaminophen can reach Tmax of 19
mcg/mL within 15-30 minutes (Lachiewicz, 2013).
Acetaminophen is generally safe for adults when taken in doses no greater than
4g/day, and in doses of 2-3 g/day for chronic use (Groudine & Fossum 2011).
Acetaminophen toxicity can occur in doses greater than the recommended amount. Also,
acetaminophen is an ingredient in cold and sinus medicines and other over-the-counter
medications. This can be a safety concern when these medications are used in
combination with prescribed medications. However, these concerns can be addressed
and alleviated in the hospital setting with diligent pharmacy, physician, and nursing
supervision.
Acetaminophen should be used with caution or avoided in patients with acute
liver disease or hypersensitivity to acetaminophen, as hepatotoxicity is a major safety
concern (Golembieewski & Mueller, 2011). Underlying causes of hepatotoxicity can
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include alcohol abuse, liver steatosis, depletion of glutathione stores, and chronic
malnutrition. Acetaminophen is metabolized by the liver through 3 enzymatic pathways:
glucuronidation, sulfation, and oxidation (Lachiewicz, 2013). The renal system is
responsible for excreting 3-5 percent of metabolized acetaminophen; therefore, this is a
medicine that should be avoided in patients with severe hypovolemia or severe renal
impairment.
Hepatotoxicity from the absorption of PO acetaminophen can result in high
concentrations in the portohepatic circulation resulting from the first pass effect
(Lachiewicz, 2013). IV acetaminophen avoids the hepatic first pass effect but is able to
accomplish higher plasma concentrations. However, there is no supporting evidence to
show that giving IV acetaminophen will result in less hepatotoxicity than occurs with the
PO or PR forms.
Intravenous Acetaminophen Administration
While the mechanism of action is unclear, there are many benefits from IV
acetaminophen. Unlike opioids, IV acetaminophen neither increases the incidence of
nausea and vomiting or respiratory depression. The drug does not cause platelet
dysfunction that can contribute to gastritis or interfere with renal function, like many
nonsteroidal anti-inflammatory inhibitors (NSAIDs) are known to do (Pasero & Stannard,
2012).
After the administration of IV acetaminophen, the onset time for action occurs
between 5 to 10 minutes, and peaks after 1 hour for analgesia purposes (Nagelhout &
Plaus, 2014). The medication lasts between four to six hours after its infusion. Also, IV
acetaminophen has been shown to have higher peak plasma and cerebrospinal fluid (CSF)
8

maximum concentrations than oral or rectal suppository forms (Singla et al., 2012).
These concentrations also peak earlier compared to the oral (PO) and suppository form
(PR) of acetaminophen. It should also be noted that IV acetaminophen’s Cmax is nearly
twice that of the PO form of acetaminophen and almost four times greater than that of the
PR form of acetaminophen (Singla et al., 2012). This means that the IV form of
acetaminophen results in a faster onset, making it more advantageous compared to the
other routes of administration.
Summary
CS are increasing every year and pain management in this population is
concerning. If surgical pain for the CS patient is not treated effectively, serious
complications such as depression and chronic pain can occur. Traditionally opioids have
been used to treat postoperative pain but are known to have serious, negative side effects.
It is recommended by the American Society of Anesthesiologists Task Force on Acute
Pain Management to use a multimodal approach to treat pain.
Multimodal therapy is designed to use nonopiod analgesics to treat pain and opioids are
given as supplemental breakthrough agents. IV acetaminophen is proven to be a safe and
effective drug when used properly and is a favorable choice for multimodal therapy.
Although the cost of IV acetaminophen has increased, it is more beneficial when
compared to other forms of acetaminophen.
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CHAPTER II – REVIEW OF LITERATURE
A systematic search for current articles was conducted using Cochrane, Pub Med,
Nursing Ovid, Medline, CINHAL, Joanna Briggs Institute, and Google Scholar, Agency
for Healthcare Research and Quality, and National Guidelines Clearinghouse. Search
terms were: ofirmev and postoperative pain management, intravenous (IV) Tylenol and
postoperative pain control, paracetamol and cesarean section, guidelines for
postoperative pain control for CS patients, and IV acetaminophen and c-sections and
reduction of pain. This search returned 525 publications.
Included articles were five years current, written in English, manufactureproduced publications, and related to a multimodal analgesic regimen. Articles were
excluded if: they were written in a language other than English, ongoing studies, partial
studies, used animals as test subjects, demonstrated conflicts of interest, or irrelevant to
CS patients receiving IV acetaminophen as a multimodal analgesic regimen. Since there
was limited data for IV acetaminophen used as a multimodal approach to pain
management for CS patients, this project synthesizes the published literature about: (a)
IV acetaminophen for pain management, (b) different surgeries that implement IV
acetaminophen for multimodal pain reduction, and (c) benefits with IV acetaminophen
for CS. Thirteen peer-reviewed articles were relevant to IV acetaminophen used in a
multimodal approach to pain management. Three of those articles are relevant to CS
patients.
Intravenous Acetaminophen for Pain Management
In a qualitative report, Groudine and Fossum (2011) examined the results of eight
different studies with multiple surgical procedures. Studies included manufacture
10

produced publications, randomized, double-blind, placebo-controlled, multicenter,
multiple-dose studies, and a meta-analysis of randomized, prospective trials. These
results showed the safety and efficacy of IV acetaminophen for various procedures,
including pediatric and pregnant patients. These authors observed that the
implementation of IV acetaminophen had a positive impact on patient care when used in
a multimodal therapy to treat acute surgical pain. Additionally, the study results revealed
a reduction in pain when IV acetaminophen was used in major surgical procedures.
Groudine and Fossum (2011) concluded that IV acetaminophen is relatively safe, but
should be used with strict clinical supervision because it is contained in many over-thecounter medications and oral narcotics. If medications are not monitored closely, there is
an increased risk of exceeding the recommended daily allowance of acetaminophen. The
authors also acknowledged that hepatic damage is related to overdose of acetaminophen
and contraindicated in patients with hepatic impairments (Groudine & Fossum, 2011).
Even so, IV acetaminophen could be a reasonable component of NOPAs because it is not
associated with increased bleeding after surgery and does not affect kidney function
(Groudine & Fossum, 2011).
Pasero and Stannard (2012) performed a qualitative, case-illustrated review study
showing the benefits of IV acetaminophen. The information revealed the results from
various case studies, including laparoscopic surgeries, major abdominal procedures,
major orthopedic surgeries, dental procedures, and pediatric procedures. This case
review evaluated the safety and effectiveness of IV acetaminophen and concluded that
the medication is beneficial for the use as an adjunct, along with other opioids, for
multimodal pain control (Pasero & Stannard, 2012).
11

It was revealed for major abdominal surgeries, 40 patients were randomized to
receive either 1000 mg of IV acetaminophen every six hours and IV meperidine for
breakthrough pain or placebo, which was IV saline every six hours and IV meperidine as
needed within a 24-hour time period. The treatment group needed less postoperative
meperidine (p < 0.05) and their visual analog scale (VAS) scores were lower (p < 0.01)
when compared to the control group (Pasero & Stannard).
IV acetaminophen has been shown to retain its safety features, even though it
reaches a higher maximum concentration (70%) and faster onset than with PO and PR
administrations. These findings help secure IV acetaminophen’s standing as an attractive
component for multimodal pain relief, based on its ability to reduce the need for narcotics
after surgery, thus reducing the risk of adverse opioid–related events (Pasero & Stannard,
2012). Adding IV acetaminophen could potentially have a dramatic impact on patient
recovery rates, as it could facilitate mobilization and rehabilitation, which could mean
reductions in health care costs and improvements in reported patient satisfaction (Pasero
& Stannard, 2012).
Macario and Royal (2011) performed a meta-analysis to assess the analgesic
benefits of IV acetaminophen for postoperative pain management for adults.
Randomized, controlled trials (RCTs) comparing IV acetaminophen vs. an alternative
analgesic or a placebo were retrieved from Medline and Cochrane library for the metaanalysis. From the RCTs, 22 studies were compared: IV acetaminophen vs. an
alternative analgesic, such as parecoxib, IV metamizol, and PO ibuprophen, (n = 8
studies) and IV acetaminophen vs. a placebo (n = 14) (Macario & Royal, 2011). The
results showed similar outcomes between IV acetaminophen and an alternative analgesic.
12

However, when the IV acetaminophen was compared to the placebo, 12 of the 14
studies found that IV acetaminophen patients experienced less pain (Macario & Royal,
2011). Even more impressive, 10 of the 14 placebo studies showed that when patients
received IV acetaminophen, they not only needed fewer opioids overall and percentages
of opioids for rescue pain, but also waited longer time intervals before needing opioids
for pain relief (Macario & Royal, 2011).
De Oliveira, Castro-Alves, and McCarthy (2015) conducted a meta-analysis that
implemented the random-effect model. The purpose of the study was to determine the
effects of pain outcomes when a single dose of systemic acetaminophen is delivered
before surgery in both adults and children. In this analysis, 11 RCTs were used to
evaluate 740 patients, 375 having received a single dose of IV acetaminophen and the
remaining 365, controls, receiving a placebo. The Jadad Scale was used to grade the
RCTs and the median, and the interquartile range was four. From the 11 RCTs, nine
studies evaluated the effect of systemic acetaminophen and noted its ability to help
reduce postoperative opioid consumption when compared to the control (De Oliveira et
al., 2015). There was a reduction of opioids needed by patients when given IV
acetaminophen compared to placebo, weighted mean difference (WMD) of -9.7; 95% CI
(-13.0 to -6.4). Also, the study showed IV acetaminophen was useful in a reduction of
early pain at rest (≤ 4 h, -1; (95% CI (-2.0 to -0.2)) and pain at movement immediately
postoperatively (24 h, -1.9; (95%CI (-2.8 to -1.0)) when compared to the control. From
this information, the researchers concluded that a single dose of IV acetaminophen is a
valuable medication to help diminish postoperative pain (De Oliveira et al., 2015).
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Konstantatos, Smith, and Angliss (2012) investigated whether the addition of IV
acetaminophen administration helped reduce discharge times in ambulatory surgery
centers. For this study, 145 patients were divided as follows: pre and postoperative
placebo (n = 50), operative IV acetaminophen and postoperative PO acetaminophen (n =
49), and pre and postoperative PO acetaminophen (n = 48). The authors determined that
time ready for discharge from the postoperative care unit did not vary among the three
groups (Konstantatos et al., 2012).
The researchers noted several limitations that may have impacted this study’s
conclusions. The dominant population of this study was young males having minor
orthopedic and plastic surgery at only one ambulatory surgery center (Konstantatos et al.,
2012). Healthy young males with an ASA I or II are less likely to develop respiratory
depression or other side effects of opioids that are seen in older patients, patients with comorbidities, and obese patients (Konstantatos et al., 2012). Another weakness of the
study could have been related to surgeons infiltrating local anesthetics at the site of
incision and anesthesia personnel using fentanyl or other opioids. The aim of the study
was to avoid altering the typical flow and treatment options used at the surgery center
(Konstantatos et al., 2012).
Surgeries Implementing Intravenous Acetaminophen for Multimodal Pain Reduction
Gynecological Procedures
Wininger et al. (2010) conducted a double-blind, placebo-controlled, parallelgroup study in 17 different facilities throughout the United States. A total of 244
abdominal laparoscopic surgery patients were placed into four groups randomly: (a) IV
acetaminophen 1 gm in 100 mL every 6 hours, (b) IV acetaminophen 650 mg in 65 mL
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every 4 hours, (c) 100 mL of IV placebo every 6 hours, and (d) 100 mL IV placebo every
4 hours. All medications were given over a 15-minute period for 24 hours after surgery.
The results showed that both IV acetaminophen groups outperformed the two placebo
groups in terms of pain relief, reducing the weighted sum of pain intensity over a 24-hour
period (1000 mg, p < 0.0007; 650 mg, p < 0.019) (Wininger et al., 2010).
Another study revealed that IV acetaminophen was given preoperatively and the
medication’s analgesic effects were assessed in 76 women who elected to have
abdominal hysterectomies (Moon, Lee, Lee, & Moon, 2011). This study was a
randomized, double-blinded and placebo-controlled, and was designed to learn whether
IV acetaminophen administered prior to surgery would decrease pain scores, lessen the
need for opioids, and reduce side effects. These patients were divided into two groups:
Group A, IV acetaminophen 2 gm, 30 minutes before surgery with general anesthesia and
Group C, IV placebo 30 minutes prior to surgery with general anesthesia. The results
showed less need for opioids in Group A compared to group C (p = 0.013) (Moon, Lee,
Lee, & Moon, 2011). It was noted that postoperative nausea and vomiting was also lower
in Group A (p = 0.05) when compared to group C. Even though the patients in Group A
needed fewer opioids and experienced less SE after surgery, they did not report a
reduction in pain intensity (Moon et al., 2011).
Spinal Procedures
An IV acetaminophen group used significantly less opioids (p = 0.015) compared
to the control group in a retrospective analysis conducted by Smith and Hoefling in 2014.
The analysis reviewed 68 EMRs, including 34 patients who were selected to be in the
control group and 34 spinal surgery patients who underwent spinal fusions with anterior
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or posterior approaches and received IV acetaminophen either preoperatively or
postoperatively (Smith & Hoefling, 2014). Members of the control group were close in
age and gender to members of the medication group; they had the same surgery
performed by the same surgeon, and received only opioids for pain control (Smith &
Hoefling, 2014). Results indicated that here was a decreased need for opioids (11.3 mg
morphine equivalent [ME]) in the group that received IV acetaminophen compared to the
control group (20.6 ME). Both groups were similar when it came to VAS scoring, and
needing post-surgery anti-emetics and laxatives (Smith & Hoefling, 2014).
Orthopedic Procedures
Total hip arthroplasties (THA) represent one of the most common
musculoskeletal surgeries and one of the most arduous to handle in terms of pain
management, due to comorbidities and to the advanced age of patients undergoing the
procedure (Singla et al., 2014). Two double-blind, parallel-group, multicenter,
randomized, placebo-controlled clinical trials were conducted on 130 participants with
similar demographics to determine efficacy and safety of a single-dose IV acetaminophen
for patients who underwent THAs. IV acetaminophen when compared to placebo, shows
a higher mean pain intensity difference (PID) with significant (p < 0.5) differences in
treatment arms.
Study one results indicated that pain relief scores were superior with IV
acetaminophen beginning at T0.25, and study two results put it superior beginning at
T0.5. Both studies continued to show favorable relief scores until T4. Rescue opioid
consumption was reduced for up to six hours in study one and almost four hours in study
two with IV acetaminophen. Essentially, both studies show that IV acetaminophen is an
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effective multimodal analgesic, which has a rapid onset, decreases rescue medication,
decreases opioid consumption by 50 percent, and reduces moderate-to-severe pain after
THAs compared to placebo.
Benefits of Intravenous Acetaminophen for Cesarean Section
Kamath and Lasrado (2014) compared the efficacy of 2 gm butorphanol (an
opioid) versus1 gm intravenous acetaminophen for elective cesarean sections and routine
gynecological procedures in a randomized parallel-group controlled trial. The 51 patients
in Group A were given 1 gm of IV acetaminophen every eight hours. The 50 women in
Group B received butorphanol 2 gm every 12 hours (Kamath & Lasrado, 2014). Pain
was measured by VAS scales at rest and while the patient inhaled deeply. These scores
were measured after 30 minutes, 2 hours, 4 hours, 6 hours, 8 hours, and increased to 12
hours, and 24 hours. Tramadol 100 mg IV was the rescue medication given if the pain
intensity was greater than five (Kamath & Lasardo, 2014).
Kamath and Lasrado’s (2014) results indicated that the Group B had better pain
ratings at 2 hours than Group A (3.613 vs. 4.20). The pain ratings in both groups
continued to decrease overtime and overall, the authors concluded that Group A was an
effective and safe analgesic and it provided better pain-control at 6 hours, 8 hours, and 24
hours than Group B (p = 0.02). The remaining time intervals show no statistically
significant difference between the two groups (Kamath & Lasardo, 2014). The study
results illustrated less rescue medication was needed in Group A (68%) than Group B
(92%) which concluded that there was a statistically significant difference (p = 0.003)
favoring IV acetaminophen to butorphanol (Kamath & Lasrado 2014).
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The authors advised that IV acetaminophen is not a good choice for monotherapy
for pain control, but noted that when used in combination with other opioids, it reduced
the side effects commonly seen with opioids (Kamath & Lasrado, 2014). Side-effects
reported included: sedation was not seen in Group A and Group B reported 47%; nausea
for Group A was 4 % compared to 14% for Group B; and Group A revealed it had less
sleep disturbances (8%) compared to Group B (25%) (Kamath & Lasrado, 2014).
A randomized, double-blind, double-dummy, parallel group placebo-controlled
clinical trial, 111 women had elective CS with spinal anesthesia, followed by a patientcontrolled epidural (Paech, McDonnell, Sinha, Baber, & Nathan, 2014). Group C, the
control group consisted of 23 women, who received a placebo, and Group PC had 30
women and they received 40 mg of IV parecoxib along with PO celecoxib 400 mg every
12 hours along with placebos. Group PA had 32 subjects and they received 2 gm IV
paracetamol (IV acetaminophen) along with 1 gm PO paracetamol at 6, 12, and 18 hours
along with placebos (Paech et al., 2014). Group PCPA had 26 women to receive 40 mg
IV parecoxib and 2gm IV paracetamol, followed by 1 gm PO paracetamol at 6,12, and 18
hours in combination with 400 mg PO celecoxib.
The results of this study concluded that all three groups continued to need pain
control from the pethidine epidural (Paech et al., 2014). The dynamic pain scores, as
measured by the verbal numerical rating score, were not different in the groups, but the
need for PO tramadol was least needed in the PCPA group (incidence 23% versus 48%,
70% and 58% in groups C, PC, and PA respectively, p = 0.004). The incidence of nausea
and sedation was stable in all groups, with very little degree in differences (range 9% to
19%) (Paech et al., 2014). Concomitant pruritus and its severity were much greater in all
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groups when compared to the control group (69%, 69% and 62 % versus 30%, p =
0.016). These results concluded that delivering COX-2 inhibitors and paracetamol, alone
or in combination, does not reduce patients’ decision to self-administer pethidine epidural
analgesia (Paech et al., 2014).
Darvish and colleagues (2013) illustrated that the combination of IV
acetaminophen and diclofenac has a better efficacy for controlling postoperative pain and
reduced the need for additional opioid consumption. The authors selected 120 women
candidates. These candidates were randomly placed into two groups. Group A
participants received a diclofenac suppository at the end of CS with an additional 1 gm
infusion of IV acetaminophen. The second group, Group B, received 20 mg bolus of
meperidine while transitioning to the recovery room (Darvish et al., 2013).
Postoperative pain was noted in the recovery room 23.3% and 38.3% in Group A
and Group B, respectively (p=0.009). Six hours after the procedure, postoperative pain
was assessed and noted to be 16.7% and 38.7% in Groups A and B, respectively
(p=0.010). Twelve hours after the procedure, pain was present and assessed to be 15%
and 38.3% for Groups A and B, respectively (p=0.002) (Darvish et al., 2013). Meperidine
was used as a supplement for pain control for both Groups A and B 6 hours after the CS
and the pain present was noted 6.7% and 26.7%, (p=0.013).
Meperidine was used as a supplemental medication for breakthrough pain 12
hours after surgery and pain present was none and 16.7%, for patients in Groups A and B,
respectively (p=0.004) (Darvish et al., 2013). The authors noted that the adverse effects
from the medications used in both groups were the same (p > 0.05). From the
information gathered, it appeared that the multimodal combination of diclofenac and IV
19

acetaminophen was a better postoperative pain control method when compared to
meperidine alone (Darvish et al., 2013).
Review of Literature Summary
Opioids are known to have many undesirable side effects. However, IV
acetaminophen has proven to be a safe and efficient means of reducing opioid
consumption. To date, no clear or established guidelines are in place for reducing postoperative pain for CS patients (Darvish et al., 2013). Since IV acetaminophen’s
introduction to the United States, however, many studies have shown its importance as a
multimodal agent for reducing the need for opioids in various surgical procedures. This
information is limited within the CS delivery population. Through the implementation of
IV acetaminophen, a safer and more reliable approach to pain control can be
implemented for CS patients. Since many opioids do contain acetaminophen, it is
important to monitor the amount of acetaminophen consumed by the patient. Proper
clinical supervision can prevent exceeding the maximum daily dose of acetaminophen.
Theoretical Framework
Implementing evidence-based practice guidelines, the anesthesia provider or
nurse anesthetist (CRNA) will ensure the best available health care techniques resulting
in favorable patient outcomes. Due to the complexity of healthcare, models or theories
can offer a framework to achieve a maximum level of wellness for patients (Riehl & Roy,
1980). Theories influence the way anesthesia providers base and formulate methods to
implement the best care and speed of recovery for their patients. The application of the
appropriate theory may encourage better techniques of nurse anesthesia practice for
promoting relief of pain for the CS patient.
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Neuman systems model was introduced in the 1970s for nursing education and
practice. This theory has undergone many refinements, but remains a holistic approach
to guiding nursing practice. The Neuman model is an open system model that deals with
stress and reactions in relation to a client or group (Neuman & Fawcett, 2002). The
theory posits that clients or groups are in a constant state of fluctuation, either moving
towards wellness or illness (Neuman & Fawcett, 2002). The goal is for a patient to
achieve harmony and stability when faced with internal or external stressors (Neuman &
Fawcett, 2002).
Each individual is considered unique and possess characteristics that are
considered normal within a basic structure (Neuman & Fawcett, 2002). Neuman’s model
shows the interrelationship of five variables that can affect the patients’ well-being: (a)
physiological, (b) psychological, (c) sociocultural, (d) developmental, and (e) spiritual
(Butts & Rich, 2015). These variables aid in adapting to stressors, whether stressors are
good or bad. According to Neuman and Fawcett (2002), these variables are part of the
client’s basic structure, as well as the normal and flexible lines of defense (LOD) and the
lines of resistance that aid in maintaining balance for the patient’s core (Neuman &
Fawcett, 2002).
Neuman’s Systems Model Diagram Explained
Neuman explains her theory by using a diagram. The illustration shows a circular
module and it is known as the basic unit or the patient’s core. It is surrounded by lines of
resistance and a normal and flexible LOD. The LOD are in place to ensure the stability
of a patient when threatened by known or unknown stressors (Neuman & Fawcett, 2002).
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The flexible LOD is the outermost boundary surrounding the core and acts as a
buffer to protect the patient’s stable state (Neuman & Fawcett, 2002). This line is
dynamic and can adapt to an emergent situation or other medical conditions, such as
dehydration or depression. If the flexible LOD is penetrated, the patient will exhibit
symptoms related to the stressor (Neuman & Fawcett, 2002).
The normal LOD is protected by the flexible LOD (Neuman & Fawcett, 2002).
The normal LOD is known to be dynamic, expanding or contracting over time. The
normal LOD and the five client variables represent the patient’s standard state of health
(Neuman & Fawcett, 2002). However, deviation from this standard determines the extent
of damage received by the stressor. Stability of the patient’s core can increase, diminish,
or stay the same based on the normal LOD ability to deal with internal or external
stressors (Neuman & Fawcett, 2002).
The innermost boundary protecting the patient’s core is the line of resistance
(Neuman & Fawcett, 2002). If the normal LOD are ineffective to an environmental
stressor, the lines of resistance aid in protecting the core’s integrity (Neuman & Fawcett,
2002). Effective lines of resistance assist in reversing damage from stressors and
reestablishing order of the system. However, if the lines of resistance prove ineffective,
permanent damage or death may result (Neuman & Fawcett, 2002).
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Primary Prevention:
Scheduled doctor's visits,
prenatal care, proper diet
and exercise, adequate rest

Tertiary Prevention:
Scheduled dosing of IV
acetaminophen to help
reduce opioid
consumption, improved
comfort, and return to
wellness

Patient's
Core

Secondary
Prevention:
Multiimodal therapy
with IV
acetaminophen prior
to CS

Figure 1. Adaptive Framework of Neuman’s Model for CS Patients
Prevention Measures
Neuman’s model is composed of primary, secondary, and tertiary preventions
used to deal with environmental stressors (Neuman & Fawcett, 2014). All three
prevention modalities act as interventions depending on the patient’s condition. Based on
the patient’s stressors and conditions, these interventions can occur either alone or
simultaneously (Zaccagnini & White, 2014).
Primary prevention is known as an intervention and wellness retention (Neuman
& Fawcett, 2002). Primary intervention is used when there is a known threat to the
patient’s basic structure but has not occurred. This primary prevention helps enable or
strengthens a system’s ability to cope with stressors, possibly even before the stressor can
affect the system (Butts & Rich 2015).
If the primary prevention is ineffective, the secondary prevention is needed to
protect the patient’s core by strengthening the internal lines of resistance (Neuman &
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Fawcett, 2002). This can be achieved by treating symptoms to provide optimal wellness
and stability. If the secondary prevention is ineffective, the patient’s core is irreparably
damaged. But, if the secondary prevention is adequate, reestablishment is made and the
system can return to its previous level of function or stabilize to a lower or even higher
level of functioning (Neuman & Fawcett, 2002).
The tertiary prevention is utilized when the secondary prevention is proven to be
effective. Once the patient begins to return to their normal state of wellness, the tertiary
prevention promotes wellness maintenance (Neuman & Fawcett, 2002). With the success
of tertiary intervention, the patient’s wellness and conservation of energy leads back to
primary prevention (Neuman & Fawcett, 2002).
The doctoral project showed how the anesthesia provider can integrate the
Neuman model in their practice when treating CS patients. The patient maintains her
health throughout her pregnancy with primary prevention. Primary prevention can be
accomplished by regular doctor’s visits, prenatal vitamins, proper diet and exercise, and
adequate rest. If the obstetric physician determines that a CS will be the best method for
delivery, it is the anesthesia provider’s goal to ensure a safe and effective means of pain
control, since surgery will be a stressor. The anesthesia provider can provide the
secondary prevention by infusing IV acetaminophen preoperatively and providing an
effective subarachnoid block containing intrathecal morphine. This intervention can
reduce the amounts of opioids postoperatively which leads to the tertiary prevention. The
tertiary intervention occurs when the patient is returning to her normal, stable state.
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Essentials of Doctoral Education for Advanced Nursing Practice
The American Association of Colleges of Nursing (AACN) notes the practicefocused doctoral programs must require “a scholarly approach to the discipline, and a
commitment to the advancement of the practice” (AACN, 2006, p. 3). The AACN urges
nurses who are expanding their knowledge for advanced care become experts for
scientific investigation and develop strong leadership skills. Ensuring the advanced nurse
is competent for specialized practice, the AACN require these essentials to be
incorporated in the education of the DNP degree.
Essential I
Essential I described the scientific underpinnings for practice and it is the
foundation of nursing practices (Chism, 2013). This essential integrates nursing theories
to guide practice which ensures optimal wellness of patients. Neuman’s model is the
framework for this doctoral project. This project’s aim was to show that the use of IV
acetaminophen used in a multimodal approach to pain therapy can help reduce the need
of opioids in CS patients.
Essential II
DNP essential II explored the advancement of quality and safe healthcare delivery
methods through scientific findings in nursing (Chism, 2013). The rates of cesarean
delivery in the United States continue to rise. This project’s purpose was to show the
addition of IV acetaminophen used in a multimodal approach for pain therapy may
reduce postoperative pain and decrease the need for opioids for the CS patient.
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Essential III
This essential focused on the integration of new research findings into nursing
practice (Chism, 2013). In order to accomplish change, there is a need for quality
improvement. By researching the literature and by a thorough collection of data,
improvements to clinical outcomes can be implemented (Moran, Burson, & Conrad,
2014). Currently, no guidelines exist for pain control for the CS patient. This project’s
aim was to show that a multimodal approach to pain could be a safer and more effective
means of reducing pain in the CS patient. Adding IV acetaminophen preoperatively and
scheduled doses postoperatively should reduce the amounts of opioids needed
postoperatively.
Essential IV
Chism (2013) illustrated that DNP graduates can improve patient care through
information technology with this essential. Information for this project was compiled by
using electronic databases. Peer-reviewed journals were located and suggested that
improper pain management techniques for CS patients can lead to chronic pain and
depression. This information indicated that a solution is necessary to improve pain
management in this particular population. The utilization of electronic medical records
was necessary to discover information for data analysis for this project.
Essential V
This essential accentuated the need for the DNP graduate to become involved
with healthcare policy and advocacy (Chism, 2013). Once the advanced practice nurse
becomes fluent with policies, this enables and prepares leadership positions for the DNP
graduate. The results of this doctoral project may influence a change in practice by
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promoting the need of a guideline to reduce pain for the CS patient. This guideline
would incorporate the use of NOPAs, specifically IV acetaminophen to reduce the need
of opioids.
Essential VI
This essential described the importance of collaboration between healthcare
professionals (Chism, 2013). Professional collaboration can provide safe, effective, and
timely patient care. This project showed the safety and efficacy of IV acetaminophen
used in parturients who will deliver via cesarean section. The results of this project can
help inform health care professionals of the benefits of a multimodal drug regimen to
reduce opioid consumption.
Essential VII
Chism (2013) informed that essential seven illustrates that the advanced nurse is
important for clinical prevention and improving the nation’s health. Improper pain
management in CS patients can lead to chronic pain, depression, and interfere with
mother and infant bonding. This doctoral project entailed statistical analysis of pain
outcomes by comparing those who received IV acetaminophen and those who did not.
Statistical evaluation can show that the addition of IV acetaminophen can possibly
improve pain scores and reduce the need of opioids in this patient population.
Essential VIII
The last essential ascertained that even though nursing is diverse, it is required for
the DNP graduate to be an expert in at least one area of nursing practices (Chism, 2013).
In order to complete this project, information was gathered and reviewed. Furthermore,
the literature recommendations were put into practice to evaluate the effectiveness of IV
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acetaminophen used in a multimodal regimen for CS patients. Inferred statistical analysis
can be presented and reported for educational advancement.
Summary of Neuman Systems Model and DNP Essentials
Theories are tools that can be used to maximize the anesthesia provider’s methods
to assist patients to return to their normal state of functioning. The Neuman systems
model is a wellness model that defined three interventions to enable a patient to return
their prior functioning level. If lines of resistance and lines of defense fail from the result
of external or internal stressors, primary, secondary, or tertiary interventions work
independently or in tandem to achieve maximum wellness for the patient. The anesthesia
provider can aid the cesarean section patient achieve maximum comfort postoperatively
through a multimodal anesthesia technique. This multimodal technique combines
neuraxial anesthesia with the addition of IV acetaminophen prior to surgical incision. IV
acetaminophen can potentially help reduce the amounts of opioids needed postoperatively
and encourage a faster and recovery of the patient.
DNP essentials can help ensure best care practices of the nurse anesthetist by
encouraging the advanced nurse to become an expert in a certain area. The essentials
encourage the advanced practice nurse to develop a complete course of action to care for
the patient most sufficiently. Through advancing technology, integrating new research in
nursing practice, collaborating with other healthcare providers, and becoming involved
with healthcare policy and advocacy, the advanced nurse is more effective and can help
improve overall patient satisfaction.
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CHAPTER III - METHODOLOGY
Design
This project is a quantitative study that compared the relationship between
mothers with CS who were given preoperative IV acetaminophen (Group A) and those
mothers who did not (Group C) in order to determine the opioids used within 24 and 48hour time period, length of hospital stay, and the amount time of first request of pain
medication. The project incorporated the use of the independent t-test and Cohen’s d test
to measure the means and effect size of both groups. A cross sectional, retrospective
chart review with quota sampling was used for the collection of data. A power analysis
with alpha of 0.05 and an effect size of 0.4 indicated that 200 subjects were needed for
each group (https://www.ai-therapy.com/psychology-statistics/sample-size-calculator).
Sample
The sampling frame consisted of women who presented for elective CS at a 211bed hospital in southeast Mississippi between January 2014 through September 2016.
Following IRB approval from USM and host facility charts were reviewed until 100
cases meeting inclusion criteria for each group were identified. Criteria selection
consisted of cases regardless of parity, gravida, and presentation if they were:


English speaking women



American Society of Anesthesiologist Classification (ASA) I or II



Ages between 18-35



Gestation term of 37-42 weeks



Singleton and multiple births



Repeat CS
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Neuraxial block anesthesia



Pfannestiel surgical incision

Exclusion criteria consisted of cases who had:


Emergent or urgent CS



Comorbidities that contributed to a higher ASA score



Chronic pain



Current infection



Greater than four hours of labor time



Liver and renal disease



Sensitivities or allergic reactions to acetaminophen



Patient-controlled analgesic pumps



ICU admission after delivery



General anesthesia or existing pain epidural



Transverse surgical incision
Variables

Independent variables for the project included:


ASA classification



Single or twin delivery



Race as identified by electronic health records (EHR) (Caucasian, African
American, or Native American)



Age in years



Length of pregnancy in weeks
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Gravida defined as the number of pregnancies



Parity defined as number of viable births



Preoperative IV acetaminophen administration



Postoperative acetaminophen administration



Anesthesia start time



Analgesics given postoperatively within 24 and 48 hours of anesthesia start
time measured in morphine milligram equivalents measured by standard
conversion chart (See Appendix E)

Dependent variables were:


Analgesics including opioids or nonsteroidal anti-inflammatory drugs
measured in morphine milligram equivalents (MME) given within a 24 and
48-hour time frame from anesthesia start time.



LOS time measured in hours, beginning with anesthesia start time until patient
was discharged home.



Time of first request of pain medication was defined by the length of time
between anesthesia start time and patient’s first request for pain medication
regardless of patient location and disposition.
Data Collection

The independent and dependent variables were collected from the electronic
medication administration record (eMAR) and the EHR and was placed in the Data
Collection Form (Appendix D). Data collected were entered into the Statistical Package
for the Social Sciences (SPSS) (IBM SPSS Statistics for Windows, Version 19.0.
Armonk, NY: IBM Corp) for data analysis. The de-identified data was stored on a
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password-protected personal computer. Data will be disposed by shredding or deleting
from the hard drive six months after all graduation requirements and
presentation/publication activities have been completed.
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CHAPTER IV – ANALYSIS OF DATA
The aim of this project was to explore the relationship between IV acetaminophen
and postoperative pain in CS patients. To determine the clinical impact of preoperative
IV acetaminophen on postoperative pain in CS patients t-test were conducted to
determine if statistical significance differences in postoperative pain medications, LOS,
and time of first request of pain medication existed between women who received IV
acetaminophen (Group A) and those who did not (Group C). Data met assumptions for ttest analysis. This chapter illustrates descriptive statistics and t-tests for four independent
groups.
Descriptive Statistics
Descriptive statistics were used to describe cases in the sample including race,
number of births, postoperative IV acetaminophen administration, gravida, parity, and
pregnancy length. All cases consisted of women who were classified as ASA II
classification. The following table describes the sample.
Table 1
Descriptive Statistics
Variable

N

Mean

Caucasian
African American
American Indian
Single Births
Twin Births
Postoperative IV
Acetaminophen
Gravida
Parity
Length of Pregnancy

114
85
1
194
6
90
200
200
200
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-

Standard
Deviation
-

Percentage
(%)
57.00
42.50
0.50
97.00
3.00
45.00

2.50
1.23
38.64

1.22
0.87
0.84

-

Bivariate Analysis
The Pearson’s Chi-Square Test is an appropriate test for unpaired data, especially
in large samples. This test was utilized to determine whether there were significant
differences with regard to ASA, race, and birth at baseline among those who received or
those who did not receive IV acetaminophen preoperatively (Table 2). The Pearson’s Chi
Square Test illustrated that there was no significant statistical difference at baseline for
race (p = 0.565). Measures of association could not be computed for ASA and birth
because there was no variability in the data. No significant differences between the two
groups were identified.
Table 2
Baseline Categorical Variables Using Pearson’s Chi-Square (n = 200)
Categorical
Variable
ASA
Race
Births (single
v. twins)

Group A
(n)
100
56
97

(%)

Group C
(n)
100
58
97

100.00
56.00
97.00

(%)

p value

100.00
58.00
97.00

NA
0.565
NA

Table 3
Baseline Continuous Variables Using An Independent t-test (n = 200)
Continuous
Variable
Gravida
Parity
Weeks of
Gestation

Group A
Mean
2.43
1.21
38.63

(sd)

Group C
Mean
2.57
1.24
38.66

1.257
092
0.91
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(sd)

p value

1.17
0.82
0.78

.417
.808
.802

Assumptions for Independent t-test
A series of two-tailed independent t-tests were used to determine if the
administration of IV acetaminophen preoperatively decreased the total MME within 24
and 48 hours, the total LOS, and the time of first request of pain medication. Data met
assumptions of normality and homogeneity of variance. See figures below.
Group MME
24 Hour
MME
C

n

Mean

Std Dev

SEM

100

45.06

25.93

2.59

A

100

47.01

23.95

2.40

Pooled

200

46.04

24.95

t

-0.55

df

198

sig (2
tailed)

0.581

Mean
Diff

-1.95

SE Diff

3.53

95%
Lower
Bound

95%
Upper
Bound

-8.92

Cohen's
d

5.01

0.078

Figure 2. MME for 24 Hours Independent t-test
Equal Variances Assumed

There was no statistically significant difference in the scores for MME in the first
24-hour for Group A (M = 47.01, SD = 25.95) and Group C (M = 45.06, SD = 25.93); t
(198) = -0.55, p = 0.581. Cohen’s d = 0.078. These results indicate preoperative
administration had no effect on postoperative use of analgesics at 24 hours. Cohen’s d
indicates there is a small effect size therefore, there is no statistical or practical
differences between the two groups.
Group MME
48 Hour
MME
C

n

Mean

Std Dev

SEM

100

47.95

24.98

2.50

A

100

58.69

24.10

2.41

Pooled

200

53.32

24.54

t

-3.10

df

198

sig (2
tailed)

0.002

Mean
Diff

-10.74

SE Diff

3.47

95%
Lower
Bound

-17.588

95%
Upper
Bound

Cohen's
d

-3.9

0.438

Figure 3. MME for 48 Hours Independent t-test
Equal Variances Assumed

There was a statistical significant difference in the scores for MME in the 48-hour
for Group C (M = 47.95, SD = 24.98) when compared to Group A (M = 58.69, SD =
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24.10); t (198) = -3.10, p = 0.002. Cohen’s d = 0. 438. These results indicate
preoperative administration had no effect on postoperative use of analgesics at 48 hours
and fewer analgesics were needed for Group C. Cohen’s d indicates there is a small
effect size therefore, there is no statistical or practical differences between the two
groups.
Group LOS

n

Mean

Std Dev

SEM

C

100

52:19:00

6:31

0:39

A

100

50:24:00

5:12

0:31

Pooled

200

51:22:00

5:22

t

df

sig (2
tailed)

2.31 198.00

0.022

Mean
Diff

1:55

SE Diff

95%
Lower
Bound

0:50

0:17

95%
Upper
Bound

Cohen's
d

3:34

0.339

Figure 4. LOS Independent t-test
Equal Variance Assumed

There was a statistically significant difference in the scores for LOS for Group A
(M = 50:24, SD = 5:12) compared to Group C (M = 52:19, SD = 6:31); t (198) = 2.31, p
= 0.022. Cohen’s d = 0.339. These results indicate preoperative administration had an
effect on LOS for CS women. Cohen’s d indicates there is a small effect size therefore,
there is no statistical or practical differences between the two groups.
Group Time
of First
Request
C

n

Mean

Std Dev SEM

100

5:22:00

5:35

0:33

A

100

4:31:00

5:45

0:34

Pooled

200

1:00:00

0:40

t

1.04

df

sig (2
tailed)

198

0.299

Mean SE Diff 95%
Diff
Lower
Bound

1:55

0:48

-0.44

95%
Upper
Bound

Cohen's
d

2:25

0.17

Figure 5. Time of First Request Independent t-test
Equal Variance Assumed

There was no statistically significant difference in the scores for time of first
request of pain medication for Group A (M = 4:31, SD = 5:45) when compared to Group
C (M = 5:22, SD = 5:35); t (198) = 1.04, p = 0.299. Cohen’s d = 0.17. These results
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indicate preoperative administration had no effect on time of first request for pain
medication. Cohen’s d indicates there is a small effect size therefore, there is no
statistical or practical differences between the two groups.
Conclusion of Data Analysis
An independent t-test was conducted to compare total MME with 24 and 48
hours, LOS, and time of first request of pain medication for CS patients who received
preoperative doses of IV acetaminophen compared with CS patients who did not receive
IV acetaminophen preoperatively. Data analysis revealed that LOS was statistically
significant (p = 0.022) in Group A. The need for MME within 24 hours and time of first
request was not significantly different between the two groups. Group C had a
statistically significant decrease in MME within 48 hours (p = 0.002).
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CHAPTER V – Conclusion
Discussion of Results and Limitations
The purpose of the retrospective chart review was to determine if the preoperative
administration of IV acetaminophen reduced the amounts of MME needed post cesarean
delivery within 24 and 48 hours, time for first intervention of analgesics, and length of
stay for patients who received preoperative IV acetaminophen compared to those who did
not. No statistical significant difference was observed between the two groups for MME
within 24 hours of CS delivery and the amount of time for first request of pain
medication. There was statistically significant difference that less MME were needed 48
hours after CS for group C when compared to group A. A statistical significant
difference was reflected for those in Group A when comparing LOS. Data was collected
and noted the presence and absence of adverse reactions. Fewer incidences of adverse
reactions were documented for Group A when compared to Group C. No statistical
analysis was conducted.
Neuman’s Logic Model was used as the framework for this doctoral project.
Group A revealed a shorter LOS at the hospital. The reduction of hospital stays aids with
tertiary prevention. Tertiary prevention is a means to revert back to a normal state of
wellness. This provides an opportunity for optimal wellness and stability.
Limitations and Barriers
Many limitations may have affected the results of the analysis. Distinct responses
to pain vary in each individual and can contribute to the inconsistent amounts of pain
medication required by each patient after cesarean delivery. Lack of consistency was
observed in the administration times of IV acetaminophen prior to CS. In addition, only
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45 percent of patients continued to receive postoperative administrations of IV
acetaminophen after surgery. Scheduled NSAIDs were administered postoperatively to
various patients while others did not receive this medication unless it was requested. A
0.4 effect size is a limitation because it is too small to find practical and statistical
significance. Sample size may not have allowed the test to be as robust for statistical
findings. The use of four different t-tests could have increased error terms and impacted
the analysis. In addition, there could be an inherent difference between the literature’s
population and the population used for this project.
Time restrictions were a consistent barrier during data collection. In order to
begin chart review, credentialing had to be obtained from the host facility. In addition,
one person at the medical facility had authorization to upload charts into a query for
review. These charts could only be reviewed Monday through Friday during the hours of
0800 to 1700.
Recommendations
It was noted that multiple types of opioids were used for breakthrough pain during
and after surgery. The literature revealed in other studies that only one type of
medication was used for breakthrough pain. Differences in mechanism of action and
pharmacokinetics in various opioids and analgesics could cause variability and an
increased amount of MME. Scheduled dosing could have contributed to a higher amount
of MME between groups. A more consistent means of providing rescue medication and
consistent IV acetaminophen administration times could have resulted in more favorable
results and could be recommended for future studies.
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Implications for Future Practice
Future adverse drug reactions and expected sequelae of opioid administration can
be reviewed. It was observed without statistical testing that Group A had less amounts of
adverse reactions. This retrospective chart review could be the premise to test if IV
acetaminophen reduces nausea and vomiting, pruritus, and constipation, as well as any
other measurable adverse reactions.
DNP Essentials Summary of Application
Essential IV focused on technology improving patient care. Electronic data bases
were needed to search for peer-reviewed journals in order to investigate whether there is
a need to treat pain postoperatively for CS mothers. EHR and eMAR were used to
collect data for sampling. Essential VI expressed the importance of collaboration
between healthcare professionals. It is crucial for the surgeon, anesthesia providers, and
nurses all be consistent in treating postoperative pain for the CS mothers. Finally,
Essential VII illustrated that the advanced practice nurse is important for improving the
nation’s help. Staying current on evidence-based practice encourages the best medical
outcomes. Using a multimodal approach for CS patients can reduce the length of stay
and potentially decrease unwanted adverse reactions and complications.
Conclusion
Literature revealed that IV acetaminophen can be used to reduce the amounts of
opioids in major orthopedic surgical procedures, spine surgery, and various other
procedures. However, this study did not illustrate a statistical significant reduction in the
MME 24 or 48 hours after surgery or an increased time of first request of pain
medication. The study did reveal a statistical significant reduction in the LOS. This
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retrospective chart review gives a baseline of comparison for probable future studies,
specifically for adverse complications or effects.
Since there is little literature concerning the use of IV acetaminophen used to
reduce opioid use for CS patients, more studies may be needed. To assure that the results
are valid or to determine if extraneous variables interfered with the results, a replication
study may be indicated. Different populations, more sample groups, and a controlled
study may offer reliable and valid results.
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APPENDIX A – Merit Health Wesley IRB Approval
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APPENDIX B – IRB Approval Letter
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APPENDIX C – Logic Model
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APPENDIX D – Data Collection Sheet
CS Data Collection Form
AGE: _______

ASA: _______

Gestation (wks.): ______

Parity: __________

Birth: Single or Multiple

Race: ________

Co-morbidities: ___________________________________________

Duration of Labor (hrs.): ___________

Spinal: __________________________________

Anesthesia Start Time: ________________

Anesthesia Stop Time: ____________________

Procedure Start Time: ________________

Procedure Stop Time: _____________________

Additional Procedures Indicated: ____________________________________________________
Receive IV acetaminophen: Y/N

Time of IV Acetaminophen: ____________________

IV Acetaminophen post op: ___________________________________________________________
Pain
Medication
Date/Time
VAS/VPS
Total
Morphine
Equivalents
Totals
PCA ordered: _______________________
Time from IV Acetaminophen to First Request Pain Medication:
________________________________________________
Adverse Reactions: Y/N If Yes, Explain: ____________________________________________
LOS in Hours (Admission to Discharge): __________________________
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APPENDIX E – Morphine Milligram Equivalent (MME) Chart

Opioid or Analgesic

Oxycodone/acetaminophen
Hydrocodone/acetaminophen
Ketorolac
Ibuprofen
Naproxen
Roxicodone
Fentanyl
Meperidine
Hydromorphone
Acetaminophen/Codeine #3
Calculated by the author using industry stated formulas.
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Morphine
Milligram
Equivalents
(MME)
7.5
5
12
3.6
4
7.5
5
5
5
4.5

APPENDIX F – Literature Matrix

Author(s)

Year

Design

1. Groudine
& Fossum

2011

Qualitative
study

Frame
work
None
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Sample

Findings

Notes

9 different
surgical
procedures
including
major
orthopedic
surgery,
abdominal
gynecologic
surgery,
laparoscopic
cholecystectom
y, cesarean
section,
pediatric
tonsillectomy,
and
laminectomy
and discectomy
procedures.
Each procedure
measured the
efficacy of IV
acetaminophen
by comparing
it with a
placebo, with
addition of
steroids,
comparing the
synergism of
the addition of
a NSAID, or
comparing it
with IM
meperidene.

This study
showed the
safety of this
non-opioid
analgesic. It
also showed a
reduction of
postoperative
pain and the
amounts of
opioids needed.
It shows IV
acetaminophen
can be used in
a multitude of
operative
procedures
including
pregnant and
pediatric
patients. This
study assessed
the efficacy of
intravenous
acetaminophen
and compared
many peerreviewed
studies.

This study
shows
many
types of
studies
with
different
outcomes
and
variables.
While this
can be
seen as a
positive
for IV
acetamino
phen, it
can affect
its
significan
ce. Due
to the
different
studies
and ways
of testing
its
effectiven
ess, it is
not
consistent.
In
addition,
many oral
opioids
contain
acetamino
phen.
Therefore,
it is
important
to monitor
its
administra
tion by
clinicians
to prevent
potential
overdose.

2. Wininger,
Miller,
Minkowitz,
Royal, Ang,
Breitmeyer,
& Singla

2010

Quantitative
Study

None

In the U.S., 17
sites enrolled
244 adult
subjects (ages
18-80) and
arranged the
subjects in 4
groups: IV
acetaminophen
1000 mg [100
mL] q6h; IV
acetaminophen
650 mg [65
mL] q4h; IV
placebo 100
mL q6h; or IV
placebo 65 mL
q4h, each
given as a 15minute
infusion after
surgery for 24
hours.

It was
determined that
both
administrations
of IV
acetaminophen
(1000mg q6h
and 650mg
q4h) were
associated with
statistically
significant
analgesic
efficacy
compared to
the placebo
groups. It was
noted that
administrations
of IV
acetaminophen
were well
tolerated in
both groups.

3. Pasero &
Stannard

2012

Qualitative
CaseIllustrated
Study

None

This study
reviews eight
separate cases,
including
laparoscopic
surgery, major
abdominal
surgery, dental
surgery, and
orthopedic
procedures.

Results show
that IV
acetaminophen
used in
conjunction
with other
NSAIDs and
opioids in a
variety of
operations, is
effective in
reducing pain
and has less
sedation when
compared to
opioid
monotherapy
alone. It is a
safer drug with
very few
interactions
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The
results
from this
study are
consistent
with other
studies
comparing
IV
acetamino
phen's
effectiven
ess and
safety
with that
of a
placebo. It
was
looking at
moderate
to severe
pain. This
study was
conducted
at several
clinical
sites. No
related
hepatic SE
were seen
in the IV
acetamino
phen
groups.
This study
shows
results of
many
surgical
procedure
s
including
laparosco
pic
procedure
s,
abdominal
procedure
s,
orthopedic
, dental,
and
pediatric
surgeries.

with other
medications.

4. Marcario
& Royal

2012

Quantitative
Study

None

Sixteen articles
from 2005
through 2010
from 9
countries were
collected and
reviewed.
These articles
contained
1,464 patients.
Twenty-two
comparison
studies were
analyzed.
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This
randomizedcontrolled trial
showed that in
7 of 8
comparator
studies, IV
acetaminophen
had similar
analgesic
outcomes.
When
comparing IV
acetaminophen
to placebo, 12
to the14 studies
found IV
acetaminophen
patients had
better analgesic
outcomes.
Further
information
showed that 10
of the 14
studies showed
less opioid
consumption
and longer time
to first rescue.

This is a
methodolo
gical RCT
comparing
IV
acetamino
phen to an
active
comparato
r and with
a placebo.

5. De
Oliveira,
Castro-Alves
& McCarthy

2015

Quantitative
Study

None

Eleven RCTs
were used to
evaluate 740
patients, 375
having
received a
single dose of
IV
acetaminophen
and the
remaining 365,
controls,
receiving a
placebo.

6.
Konstantatos,
Smith, &
Angliss

2012

Quantitative
Study

None

For this study,
145 patients
were divided as
follows: pre
and
postoperative
placebo (n =
50), operative
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From the 11
RCTs, nine
studies
evaluated the
effect of
systemic
acetaminophen
and noted its
ability to help
reduce
postoperative
opioid
consumption
when
compared to
the control.
There was a
reduction of
opioids needed
by patients
when given IV
acetaminophen
compared to
placebo,
weighted mean
difference
(WMD) of 9.7; 95% CI (13.0 to -6.4).
Also, the study
showed IV
acetaminophen
was useful in a
reduction of
early pain at
rest (≤ 4 h, -1;
(95%CI (-2.0
to -0.2)) and
pain at
movement
immediately
postoperatively
(24 h, -1.9;
(95%CI (-2.8
to -1.0)) when
compared to
the control.
It was
determined
from the 3
groups that
time ready for
discharge from
the
postoperative

Researche
rs found
that a
single
dose of IV
acetamino
phen is a
valuable
medicatio
n to help
diminish
postoperat
ive pain.

This study
focused
on the
addition
of IV
acetamino
phen
administra

7. Wininger,
Miller,
Minkowitz
Royal, Ang,
Breitmeyer,
& Singla

2010

Quantitative
Study

None

8. Moon,
Lee, Lee, &
Moon

2011

Quantitative
Study

None
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IV
acetaminophen
and
postoperative
PO
acetaminophen
(n = 49), and
pre and
postoperative
PO
acetaminophen
(n = 48).
For this study,
244 abdominal
laparoscopic
surgery
patients were
placed into
four groups
randomly: (a)
IV
acetaminophen
1 gm in 100
mL every 6
hours, (b) IV
acetaminophen
650 mg in 65
mL every 4
hours, (c) 100
mL of IV
placebo every
6 hours, and
(d) 100 mL IV
placebo every
4 hours.

care unit did
not vary among
the three
groups.

tion to
determine
if the
medicatio
n helped
reduce
discharge
times in
ambulator
y surgery
centers.

The results
showed that
both IV
acetaminophen
groups
outperformed
the two
placebo groups
in terms of
pain relief,
reducing the
weighted sum
of pain
intensity over a
24-hour period
(1000 mg, P <
0.0007; 650
mg, P < 0.019).

For this
study,76
women who
elected to have
abdominal
hysterectomies
were divided
into two
groups. Group
C, the control
group and
Group A, those
who received

The results
showed less
need for
opioids in
Group A
compared to
group C (P =
0.013)

This study
is
conducted
in 17
facilities
in the US.
Laparosco
pic
surgery
patients
were
randomly
placed
into four
groups to
compare
IV
acetamino
phen to
placebo.
These
medicatio
ns were
time
scheduled
and were
given 24
hours after
surgery.
This study
was a
randomize
d, doubleblinded
and
placebocontrolled,
and was
designed
to learn
whether
IV

IV
acetaminophen
.

9. Smith &
Hoefling

2014

Quantitative
Study

None

This study
showed the
results of 68
patients who
underwent
spinal surgery
with anterior
and posterior
approaches.
Half received
IV
acetaminophen
and the other
half was the
control group.
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Results
indicated that
here was a
decreased need
for opioids
(11.3 mg
morphine
equivalent
[ME]) in the
group that
received IV
acetaminophen
compared to
the control
group (20.6
ME). Both
groups were
similar when it
came to visual
analog pain
scores (VAS)
pain scores,
and needing
post-surgery
anti-emetics
and laxatives

acetamino
phen
administer
ed prior to
surgery
would
decrease
pain
scores,
lessen the
need for
opioids,
and
reduce
side
effects.
An IV
acetamino
phen
group
used
significant
ly less
opioids (p
= 0.015)
compared
to the
control
group in a
retrospecti
ve
analysis
for spinal
surgery.

10. Singla,
Hale, Davis,
Bekker,
Gimbel, Jahr,
Royal, Ang,
& Viscusi

2014

Quantitative
Study

None

This was a
double -study
and it reviewed
130
participants
with similar
demographics
to determine
efficacy and
safety of a
single-dose IV
acetaminophen
for patients
who underwent
THAs.
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IV
acetaminophen
when
compared to
placebo, shows
a higher mean
pain intensity
difference
(PID) with
significant
(P<0.5)
differences in
treatment arms.

Two
doubleblind,
parallelgroup,
multicente
r,
randomize
d,
placebocontrolled
clinical
trials were
conducted
on 130
participant
s with
similar
demograp
hics to
determine
efficacy
and safety
of a
singledose IV
acetamino
phen for
patients
who
underwent
THAs.

11. Kamath
& Lasrado

2014

Quantitative
Study

None

This study was
a randomized
parallel-group
controlled trial.
It compared the
postoperative
use of 1gm of
IV
acetaminophen
or 2 gm IV
butophanol for
postoperative
analgesia for
cesarean
section and
other
gynecological
procedures.
Tramadol was
used as a recue
medication for
breakthrough
pain.
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Either IV
acetaminophen
or IV
butophanol
was given
postoperatively
. Pain intensity
was measured
with the VAS
scores between
the two groups
at multiple
time intervals
for a 24-hour
time period.
Results showed
that the
butorphanol
group had
better pain
rating within
the first two
hours but IV
acetaminophen
resulted in
lower pain
scores after six
hours after
surgical
procedure.
Within the 24hour time
period, the
VAS scores
were
dramatically
lower in the IV
acetaminophen
group (p =
0.02) when
compared to
the
butorphanol
group.

IV
acetamino
phen was
an
effective
and safe
analgesic,
and that it
provided
better pain
controlwith fewer
side
effects-for
the
members
of Group
A than
butorphan
ol
provided
for Group
B (p =
0.02).

12. Paech,
McDonnell,
Sinha, Baber,
& Nathan

2014

Quantitative
Study

None

This was a
randomized,
double blind,
doubledummy,
parallel group
placebocontrolled
clinical trial for
patients having
cesarean
section with
neuraxial
anesthesia
along with
patient
controlled
epidural with
pethidine.
Patients were
divided into
three groups;
control group
who had
placebo (Group
C), those who
received 40 mg
of IV
parecoxib and
400 mg of PO
celecoxib at 12
hours (Group
PC), 2 gm IV
acetaminophen
followed by 1
gm of the oral
administration
(Group PA),
and the last
two groups
combined
(Group PCPA).
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The authors
wanted to
know if there
was a decrease
in the use of
the patient
controlled
pethidine
epidural
infusion and
postoperative
pain for 111
women: Group
C (n = 23),
Group PC (n =
30), Group PA
(n = 32), and
Group PCPA
(n = 26). A
difference was
not shown
between the
four groups
regarding
pethidine
consumption (p
= 0.84). Pain
scores did not
differ between
the groups but
the authors
show that the
request for
tramadol was
less in Group
PCPA
(incidence of
23% (p =
0.004)
compared to
48%, 70%, and
58% for Group
C, Group PC,
and Group
PA).

The
dynamic
pain
scores, as
measured
by the
verbal
numerical
rating
score,
were not
different
in the
groups,
but the
need for
PO
tramadol
was least
needed in
the PCPA
group
(incidence
23%
versus
48%, 70%
and 58%
in groups
C, PC,
and PA
respective
ly, P =
0.004).

13. Darvish,
Ardestani,
Shali, & Tajik

2013

Quantitative
Study

None

For this study,
120 subjects
who had
elective
cesarean
sections were
randomly
selected to
show whether
postoperative
pain was
controlled
more
effectively for
those who
received a
diclofenac
suppository
postoperatively
along with 1
gm of IV
acetaminophen
(Group A) or
those who
received a
bolus of IV
meperidine 20
mg (Group B)
postoperatively
. Meperidine
was used for
breakthrough
pain and these
results were
compared.
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Postoperative
pain was less
in Group A
(23.3%)
compared to
Group B
(38.3%), (p =
0.009). Six
hours after
surgery Group
A experienced
less pain than
Group B,
16.7% and
38.7%
respectively (p
= 0.010). Pain
was shown to
be less 12 after
surgery for
Group A, p =
0.002.
Meperidine
used for
breakthrough
pain was the
same for both
groups
postoperatively
(p > 0.5). The
addition of
meperidine
was less six
hours
postoperatively
for Group A
(6.7%)
compared to
Group B
(26.7%), p =
0.013. After
12 hours,
Group A need
no additional
Meperidine
compared to
Group B,
which received
16.7% (p =
0.004).

The
multimod
al
combinati
on of
diclofenac
and IV
acetamino
phen was
a better
postoperat
ive pain
control
method
when
compared
to
meperidin
e alone.
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